121 related articles for article (PubMed ID: 6212270)
1. [The adverse effects of thioureylene antithyroid drugs (author's transl)].
Nakashima T; Okamura K; Yoshinari M; Shiroozu A; Nishitani H; Okabe N; Inoue K; Omae T
Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):225-33. PubMed ID: 6212270
[TBL] [Abstract][Full Text] [Related]
2. [Side effects of antithyroid drugs].
Shigemasa C; Noguchi T; Onoyama S; Okamura Y; Yoshida A; Mashiba H; Abe K
Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1160-7. PubMed ID: 6689305
[TBL] [Abstract][Full Text] [Related]
3. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
Kubota S
Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
[TBL] [Abstract][Full Text] [Related]
4. Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: efficacy and adverse reactions during initial treatment and long-term outcome.
Sato H; Minagawa M; Sasaki N; Sugihara S; Kazukawa I; Minamitani K; Wataki K; Konda S; Inomata H; Sanayama K; Kohno Y
J Pediatr Endocrinol Metab; 2011; 24(5-6):257-63. PubMed ID: 21823520
[TBL] [Abstract][Full Text] [Related]
5. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease.
Kallner G; Vitols S; Ljunggren JG
J Intern Med; 1996 Jun; 239(6):525-9. PubMed ID: 8656146
[TBL] [Abstract][Full Text] [Related]
6. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero.
Eisenstein Z; Weiss M; Katz Y; Bank H
Eur J Pediatr; 1992 Aug; 151(8):558-9. PubMed ID: 1505570
[TBL] [Abstract][Full Text] [Related]
7. [The effect of maternal hyperthyroidism and its treatment on fetus-maternal ingestion of antithyroid drug, maternal hyperthyroidism, and congenital malformation (author's transl)].
Momotani N
Horumon To Rinsho; 1981 Jul; 29(7):783-7. PubMed ID: 6895490
[No Abstract] [Full Text] [Related]
8. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
[TBL] [Abstract][Full Text] [Related]
9. Adverse immunologic effects of antithyroid drugs.
Wing SS; Fantus IG
CMAJ; 1987 Jan; 136(2):121-7. PubMed ID: 3539299
[TBL] [Abstract][Full Text] [Related]
10. Which anti-thyroid drug?
Cooper DS
Am J Med; 1986 Jun; 80(6):1165-8. PubMed ID: 3755286
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects related to antithyroid drugs and their dose regimen.
Romaldini JH; Werner MC; Bromberg N; Werner RS
Exp Clin Endocrinol; 1991 May; 97(2-3):261-4. PubMed ID: 1915643
[No Abstract] [Full Text] [Related]
12. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of serious hepatic injury caused by antithyroid drugs].
Grzywa M; Orłowska-Florek R; Grzywa-Celińska A
Endokrynol Pol; 2009; 60(5):396-400. PubMed ID: 19885811
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
15. Lupus erythematosus-like syndrome induced by thiamazole and propylthiouracil.
Sato-Matsumura KC; Koizumi H; Matsumura T; Takahashi T; Adachi K; Ohkawara A
J Dermatol; 1994 Jul; 21(7):501-7. PubMed ID: 8089372
[TBL] [Abstract][Full Text] [Related]
16. [Childhood Graves' disease].
Sasaki N; Sato K
Nihon Rinsho; 2006 Dec; 64(12):2308-11. PubMed ID: 17154097
[TBL] [Abstract][Full Text] [Related]
17. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose.
Cooper DS; Goldminz D; Levin AA; Ladenson PW; Daniels GH; Molitch ME; Ridgway EC
Ann Intern Med; 1983 Jan; 98(1):26-9. PubMed ID: 6687345
[TBL] [Abstract][Full Text] [Related]
18. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone autoantibodies (THAA) in two cases of Graves' disease: effects of antithyroid drugs, prednisolone, and subtotal thyroidectomy.
Nakamura S; Sakata S; Shima H; Komaki T; Kojima N; Kamikubo K; Yasuda K; Miura K
Endocrinol Jpn; 1986 Dec; 33(6):751-9. PubMed ID: 3582264
[TBL] [Abstract][Full Text] [Related]
20. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
Dai W; Zhang J; Zhan Z; Xu B; Jin H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
